Evidence map›Paper›PMID 40375322›Full record

ArticleBreast cancer research : BCR2025

CD105

Eric G Carlson, Jennifer C Lopez, Yukiko Yamaguchi, Jackson Gibson, Saul J Priceman, Mark A LaBarge

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Ageing, immune fitness and cancer.Nature reviews. Cancer · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Eric G CarlsonDepartment of Population Sciences, City of Hope, Duarte, CA, USA.
Jennifer C LopezDepartment of Population Sciences, City of Hope, Duarte, CA, USA.
Yukiko YamaguchiDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Jackson GibsonDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Saul J PricemanDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
Mark A LaBargeDepartment of Population Sciences, City of Hope, Duarte, CA, USA. mlabarge@coh.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAging is the greatest risk factor for breast cancer, and although epithelial cells are the source of carcinomas, epithelial changes alone do not fully explain cancer susceptibility. Fibroblasts and macrophages are key stromal constituents around the cells of origin for cancer in breast tissue. With age, macrophages surrounding terminal ductal lobular units (TDLUs) become increasingly immunosuppressive. CD105

methodsPrimary peri-epithelial fibroblast cultures were established from prophylactic and reduction mammoplasties from 30 women ranging in age from 16 to 70 years and from BRCA1 mutation carriers. Growth characteristics, transcriptional profiles, differentiation potential, and secreted proteins were profiled for fibroblast subtypes from diverse donors. Co-cultures with fibroblasts, macrophages, and T cells were used to ascertain the functional role played by CD105

resultsWe found that peri-epithelial CD105

conclusionsEstablishment of a coculture system to dissect the molecular circuits between CD105

Indexed as

Breast NeoplasmsEndoglinFibroblastsAdolescentAdultAgedBRCA1 ProteinCancer-Associated FibroblastsCoculture TechniquesFemaleHumansMacrophagesMiddle AgedTumor MicroenvironmentYoung AdultBRCA1 ProteinEndoglinENG protein, humanAgingBRCA1ImmunosuppressiveIntralobular fibroblastsMacrophages

Identifiers

PMID40375322
PMCPMC12079957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.